Krisztina M. Zsebo, Ph.D. Chief Executive Officer and Director

Dr. Zsebo is a biopharmaceutical veteran with 24 years of experience in the industry, Dr. Zsebo has been involved in numerous successful ventures. She is CEO of Celladon Corporation, La Jolla, CA. Prior to joining Celladon, she was a Venture Partner at Enterprise Partners Venture Capital, and held executive positions at Remedyne Corporation, Connetics, ALZA, Cell Genesys, and Amgen.

At ALZA Corporation Dr. Zsebo was responsible for the division which developed and filed the NDA for ViadurŽ, an implantable drug/device for prostate cancer patients now marketed by Bayer Corporation. At Cell Genesys, where she was Executive Vice President of Research and Product Development, she was responsible for filing their first IND for a gene therapy product for AIDS. She also managed Cell Genesys' Xenotech division, which was spun off to become Abgenix, one of the most successful biotech companies. Earlier in her career, Kris spent eight years at Amgen in research and product development where she worked on the discovery of NEUPOGENŽ, as well as STEMGENŽ, and various aspects of EPOGENŽ development.